Significant relationships between QOL measures on infusion day and day 7. by Jordan K. Abbott (8934239)

Subjects:

Number of participants showing improved, decreased, or no change in task performance with and without PSAPs. by Maxime Perron (16618003)

EF-24 induces significant transcriptional changes in K-562 cells. by Ajeet P. Singh (22298432)

Subjects:

Flow diagram of systematic literature review describing behavior change interventions to improve antimicrobial use and stewardship in the animal and human health sectors. by Jessica Craig (409538)

Subjects:

Correlations of cytokines that significantly change between the pre-infusion and post-infusion blood draws pearson’s correlation between cytokine pairs is indicated by color and si... by Jordan K. Abbott (8934239)

Subjects:

Summary of significant treatment × time effect. by Wensheng Xiao (16557866)

Statistically significant changes between assessments for substance dependence (SDS), psychological distress (K10), and quality of life (EQoL) at four standardised timepoints, rout... by Theresa Caruana (15628074)

Change in health utilization measures by group and difference in magnitude of change between groups. by Emily Lyles (3174990)

Subjects:

Summary of significant single-arm time effect. by Wensheng Xiao (16557866)

Statistically-significant cytokine changes between the pre-infusion and post-infusion blood draws plot of the mean (dot) and confidence interval (whiskers) for the coefficients of... by Jordan K. Abbott (8934239)

Subjects:

Estimated short- and long-term cumulative changes in CRC incidence and CRC mortality attributable to screening, diagnosis, and treatment decreases in 2020 and 2021. by Joachim Worthington (8394213)

Subjects:

Change in quality of life over time. by Shayan Shirazian (9922110)

Subjects:

Change in health care-seeking and medicines for household member illness. by Emily Lyles (3174990)

Subjects:

Combined decitabine and Taxol decreases MCF-7/Taxol cells proliferation and can improve their chemosensitivity. by Weihua Gong (471435)

Clinical and laboratory measurements of patients with ALS (N = 13; Mean±SD; ns = not significant; nd = not determined; * = evidence of subgroup responsiveness). by Ann Logan (9361)

Field Site of Red Clay Subgrade Diseases in Zhuzhou. by Quan Shen (37564)

Subjects:

Number and percentage of AE patients with detectable Em2+ antibodies at different visits and significance level in binominal test. by Beate Grüner (301524)

Subjects:

Change in log health expenditures for most recent care and in the preceding month^a. by Emily Lyles (3174990)

Subjects:

Species richness decreases significantly with increasing percent disturbance. by Catherine L. Cardelús (6429320)

Summary of post-treatment CAPS score changes from MDMA-AT publications. by Filip Stanicic (17808254)

Subjects: